These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7095864)

  • 1. [Clinical experience with non-specific broad-spectrum antibacterial chemotherapy (author's transl)].
    Shah PM; Siegel K; Stille W
    Infection; 1982; 10(2):85-9. PubMed ID: 7095864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad spectrum beta-lactam combinations--a new principle of antibacterial treatment.
    Stille W
    J Antimicrob Chemother; 1983 May; 11 Suppl B():149-51. PubMed ID: 6619024
    [No Abstract]   [Full Text] [Related]  

  • 3. [The clinical view of aminoglycoside antibiotics].
    Lüthy R
    Adv Clin Pharmacol; 1978; 15():119-26. PubMed ID: 676870
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preventive and therapeutic application possibilities of newer antibiotics (author's transl)].
    Marget W
    MMW Munch Med Wochenschr; 1979 Sep; 121(36):1133-6. PubMed ID: 114782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS; Keys TF
    Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoglycoside antibiotics in infectious diseases. An overview.
    Siegenthaler WE; Bonetti A; Luthy R
    Am J Med; 1986 Jun; 80(6B):2-14. PubMed ID: 3524216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibiotic-induced diseases. Aminoglycoside-induced renal lesions].
    Gioannini P
    Minerva Med; 1978 Dec; 69(61):4215-25. PubMed ID: 366465
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
    Agence française de sécurité sanitaire des produits de santé
    Med Mal Infect; 2012 Jul; 42(7):301-8. PubMed ID: 22770656
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of severe infections in patients with cancer. The role of new acyl-penicillins.
    Klastersky J
    Arch Intern Med; 1982 Oct; 142(11):1984-7. PubMed ID: 6215007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
    Peterson LR; Gerding DN; Moody JA; Fasching CE
    Antimicrob Agents Chemother; 1984 May; 25(5):545-52. PubMed ID: 6329087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost comparison of two antimicrobial regimens for treating mixed aerobic-anaerobic infections.
    Scheife RT; Tally FP; McGowan K; Gorbach SL
    Am J Hosp Pharm; 1981 Oct; 38(10):1466-9. PubMed ID: 7294038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis.
    Smith AL; Doershuk C; Goldmann D; Gore E; Hilman B; Marks M; Moss R; Ramsey B; Redding G; Rubio T; Williams-Warren J; Wilmott R; Wilson HD; Yogev R
    J Pediatr; 1999 Apr; 134(4):413-21. PubMed ID: 10190914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive increase in antibiotic resistance of gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance.
    Cross AS; Opal S; Kopecko DJ
    Arch Intern Med; 1983 Nov; 143(11):2075-80. PubMed ID: 6639227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis.
    Michalsen H; Bergan T
    Scand J Infect Dis Suppl; 1981; 29():92-7. PubMed ID: 6947408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The combination therapy of amikacin and beta-lactam antibiotic in the severe bacterial infections (author's transl)].
    Takigami T
    Jpn J Antibiot; 1982 Feb; 35(2):369-74. PubMed ID: 7087174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in antimicrobial therapy.
    Parry MF
    Del Med J; 1978 Jan; 50(1):33-8. PubMed ID: 631383
    [No Abstract]   [Full Text] [Related]  

  • 17. Empiric therapy of febrile granulocytopenic patients.
    Hopefl AW
    Am J Hosp Pharm; 1979 Feb; 36(2):178-87. PubMed ID: 369364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dosage bactericidal chemotherapy in intensive care (author's transl)].
    Lackner F; Wagner H
    Wien Klin Wochenschr; 1974 Feb; 86(4):85-91. PubMed ID: 4439944
    [No Abstract]   [Full Text] [Related]  

  • 19. Prudent use of the aminoglycosides.
    Gregory D; Hirschmann JV
    Postgrad Med; 1978 Sep; 64(3):97-102, 104. PubMed ID: 704499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of aminoglycosides in surgical infections.
    Stone HH; Kolb LD; Geheber CE; Dawkins EJ
    Ann Surg; 1976 Jun; 183(6):660-6. PubMed ID: 973753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.